Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,379 | -4,097 | -2,519 | -1,371 | -512 |
| Depreciation Amortization | 17 | 59 | 44 | 29 | 15 |
| Accounts receivable | -105 | 474 | 320 | 9 | -1,431 |
| Accounts payable and accrued liabilities | 192 | -30 | N/A | 165 | 1,352 |
| Other Working Capital | -1,718 | 380 | -276 | 74 | -200 |
| Other Operating Activity | 121 | -116 | 249 | 243 | 241 |
| Operating Cash Flow | $-2,872 | $-3,330 | $-2,182 | $-851 | $-535 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,009 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,173 | -15 | -7 | -3 | -3 |
| Purchase Sale Intangibles | -4 | -45 | -42 | -13 | -5 |
| Other Investing Activity | -4 | -245 | -42 | -13 | -5 |
| Investing Cash Flow | $-6,186 | $-260 | $-49 | $-16 | $-8 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,878 | -1,877 | -202 | -201 |
| Common Stock Issued | N/A | 29,458 | 29,482 | 5,885 | 134 |
| Other Financing Activity | 0 | 18 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $27,598 | $27,605 | $5,683 | $-67 |
| Exchange Rate Effect | 2 | -56 | 1 | -66 | -28 |
| Beginning Cash Position | 25,610 | 1,658 | 1,658 | 1,658 | 1,659 |
| End Cash Position | 16,554 | 25,610 | 27,033 | 6,408 | 1,021 |
| Net Cash Flow | $-9,056 | $23,952 | $25,375 | $4,750 | $-638 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,872 | -3,330 | -2,182 | -851 | -535 |
| Capital Expenditure | -1,173 | -15 | -7 | -3 | -3 |
| Free Cash Flow | -4,045 | -3,345 | -2,189 | -854 | -538 |